サマリー

市場の分析と洞察ニューロサイエンスの世界市場
ニューロサイエンスの世界市場規模は、2021年の260億米ドルから、2022年から2028年の間に年平均成長率3.7%で340億米ドルに達すると予測されます。

本レポートは、業界標準の分析精度と高いデータ整合性により、世界の神経科学市場で利用可能な主要機会を明らかにし、プレイヤーが市場での強力な地位を獲得するのに役立つ素晴らしい試みを行っています。本レポートの購入者は、世界の神経科学市場の全体規模（売上高）を含む、検証済みで信頼できる市場予測にアクセスすることができます。
全体として、本レポートはプレイヤーが競合他社に対して優位に立ち、世界の神経科学市場で永続的な成功を収めるための効果的なツールであることが証明されています。本レポートで提供されるすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証され、再確認されたものです。本レポートを執筆したアナリストは、世界のNeuroscience市場を詳細に調査するため、独自の業界最高水準の調査・分析アプローチをとりました。

世界のニューロサイエンスの範囲と市場規模
ニューロサイエンスの市場は、プレイヤー、地域（国）、タイプ、用途別に分類されています。世界のNeuroscience市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるようになることでしょう。セグメント分析では、2017-2028年の期間において、タイプ別の収益と予測、アプリケーション別の収益と予測に焦点を当てます。

企業別
シーメンス・ヘルヒネアーズ
GEヘルスケア
フィリップス
キヤノン
日立
メドトロニック
ライカマイクロシステムズ
ツァイス
ニコン
日本電子株式会社
ナトゥスメディカル
日本光電工業
ニューロペース
日本光電工業
日本光電工業
ノルダスインフォメーションテクノロジー
プレクソン
ニューロネクサス
フェニックス・テクノロジー・グループ

タイプ別セグメント
全脳イメージング
神経顕微鏡
電気生理技術
神経細胞マニピュレーション
脳定位固定手術
動物行動学
その他

用途別セグメント
学術機関
病院
研究機関
その他

地域別
北米
米国
カナダ

アジア・パシフィック
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア

欧州
ドイツ
フランス
英国
イタリア
ロシア
その他の欧州

中南米
メキシコ
ブラジル
アルゼンチン
ラテンアメリカの残りの部分

中近東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
その他のMEA

ページTOPに戻る

目次

1 REPORT OVERVIEW 1
1.1 STUDY SCOPE 1
1.2 MARKET ANALYSIS BY TYPE 2
1.2.1 GLOBAL NEUROSCIENCE MARKET SIZE GROWTH RATE BY TYPE: 2017 VS 2021 VS 2028 2
1.2.2 WHOLE BRAIN IMAGING 3
1.2.3 NEURO-MICROSCOPY 4
1.2.4 ELECTROPHYSIOLOGY TECHNOLOGIES 5
1.2.5 NEURO-CELLULAR MANIPULATION 6
1.2.6 STEREOTAXIC SURGERIES 7
1.2.7 ANIMAL BEHAVIOR 8
1.3 MARKET BY APPLICATION 9
1.3.1 GLOBAL NEUROSCIENCE MARKET SHARE BY APPLICATION: 2017 VS 2021 VS 2028 10
1.3.2 ACADEMIC INSTITUTES 10
1.3.3 HOSPITALS 11
1.3.4 RESEARCH INSTITUTES 12
1.4 STUDY OBJECTIVES 12
1.5 YEARS CONSIDERED 13
2 GLOBAL GROWTH TRENDS 14
2.1 GLOBAL NEUROSCIENCE MARKET PERSPECTIVE (2017-2028) 14
2.2 NEUROSCIENCE GROWTH TRENDS BY REGION 15
2.2.1 NEUROSCIENCE MARKET SIZE BY REGION: 2017 VS 2021 VS 2028 15
2.2.2 NEUROSCIENCE HISTORIC MARKET SIZE BY REGION (2017-2022) 16
2.2.3 NEUROSCIENCE FORECASTED MARKET SIZE BY REGION (2023-2028) 17
2.3 NEUROSCIENCE MARKET DYNAMICS 17
2.3.1 NEUROSCIENCE INDUSTRY TRENDS 17
2.3.2 NEUROSCIENCE MARKET DRIVERS 18
2.3.3 NEUROSCIENCE MARKET CHALLENGES AND RESTRAINTS 19
3 COMPETITION LANDSCAPE BY KEY PLAYERS 20
3.1 GLOBAL TOP NEUROSCIENCE PLAYERS BY REVENUE 20
3.1.1 GLOBAL TOP NEUROSCIENCE PLAYERS BY REVENUE (2017-2022) 20
3.1.2 GLOBAL NEUROSCIENCE REVENUE MARKET SHARE BY PLAYERS (2017-2022) 21
3.2 GLOBAL NEUROSCIENCE MARKET SHARE BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3) 22
3.3 PLAYERS COVERED: RANKING BY NEUROSCIENCE REVENUE 23
3.4 GLOBAL NEUROSCIENCE MARKET CONCENTRATION RATIO 24
3.4.1 GLOBAL NEUROSCIENCE MARKET CONCENTRATION RATIO (CR5 AND HHI) 24
3.4.2 GLOBAL TOP 3 AND TOP 5 COMPANIES BY NEUROSCIENCE REVENUE IN 2021 25
3.5 NEUROSCIENCE KEY PLAYERS HEAD OFFICE AND AREA SERVED 26
3.6 KEY PLAYERS NEUROSCIENCE PRODUCT SOLUTION AND SERVICE 27
3.7 MERGERS & ACQUISITIONS, EXPANSION PLANS 28
4 NEUROSCIENCE BREAKDOWN DATA BY TYPE 29
4.1 GLOBAL NEUROSCIENCE HISTORIC MARKET SIZE BY TYPE (2017-2022) 29
4.2 GLOBAL NEUROSCIENCE FORECASTED MARKET SIZE BY TYPE (2023-2028) 30
5 NEUROSCIENCE BREAKDOWN DATA BY APPLICATION 31
5.1 GLOBAL NEUROSCIENCE HISTORIC MARKET SIZE BY APPLICATION (2017-2022) 31
5.2 GLOBAL NEUROSCIENCE FORECASTED MARKET SIZE BY APPLICATION (2023-2028) 32
6 NORTH AMERICA 33
6.1 NORTH AMERICA NEUROSCIENCE MARKET SIZE (2017-2028) 33
6.2 NORTH AMERICA NEUROSCIENCE MARKET SIZE BY TYPE 33
6.2.1 NORTH AMERICA NEUROSCIENCE MARKET SIZE BY TYPE (2017-2022) 33
6.2.2 NORTH AMERICA NEUROSCIENCE MARKET SIZE BY TYPE (2023-2028) 34
6.2.3 NORTH AMERICA NEUROSCIENCE MARKET SHARE BY TYPE (2017-2028) 35
6.3 NORTH AMERICA NEUROSCIENCE MARKET SIZE BY APPLICATION 35
6.3.1 NORTH AMERICA NEUROSCIENCE MARKET SIZE BY APPLICATION (2017-2022) 35
6.3.2 NORTH AMERICA NEUROSCIENCE MARKET SIZE BY APPLICATION (2023-2028) 36
6.3.3 NORTH AMERICA NEUROSCIENCE MARKET SHARE BY APPLICATION (2017-2028) 36
6.4 NORTH AMERICA NEUROSCIENCE MARKET SIZE BY COUNTRY 37
6.4.1 NORTH AMERICA NEUROSCIENCE MARKET SIZE BY COUNTRY (2017-2022) 37
6.4.2 NORTH AMERICA NEUROSCIENCE MARKET SHARE BY COUNTRY (2023-2028) 37
6.4.3 UNITED STATES 39
6.4.4 CANADA 40
7 EUROPE 41
7.1 EUROPE NEUROSCIENCE MARKET SIZE (2017-2028) 41
7.2 EUROPE NEUROSCIENCE MARKET SIZE BY TYPE 41
7.2.1 EUROPE NEUROSCIENCE MARKET SIZE BY TYPE (2017-2022) 41
7.2.2 EUROPE NEUROSCIENCE MARKET SIZE BY TYPE (2023-2028) 42
7.2.3 EUROPE NEUROSCIENCE MARKET SHARE BY TYPE (2017-2028) 43
7.3 EUROPE NEUROSCIENCE MARKET SIZE BY APPLICATION 43
7.3.1 EUROPE NEUROSCIENCE MARKET SIZE BY APPLICATION (2017-2022) 43
7.3.2 EUROPE NEUROSCIENCE MARKET SIZE BY APPLICATION (2023-2028) 44
7.3.3 EUROPE NEUROSCIENCE MARKET SHARE BY APPLICATION (2017-2028) 44
7.4 EUROPE NEUROSCIENCE MARKET SIZE BY COUNTRY 45
7.4.1 EUROPE NEUROSCIENCE MARKET SIZE BY COUNTRY (2017-2022) 45
7.4.2 EUROPE NEUROSCIENCE MARKET SIZE BY COUNTRY (2023-2028) 45
7.4.3 GERMANY 47
7.4.4 FRANCE 48
7.4.5 U.K. 49
7.4.6 ITALY 50
7.4.7 RUSSIA 51
8 ASIA-PACIFIC 52
8.1 ASIA-PACIFIC NEUROSCIENCE MARKET SIZE (2017-2028) 52
8.2 ASIA-PACIFIC NEUROSCIENCE MARKET SIZE BY TYPE 52
8.2.1 ASIA-PACIFIC NEUROSCIENCE MARKET SIZE BY TYPE (2017-2022) 52
8.2.2 ASIA-PACIFIC NEUROSCIENCE MARKET SIZE BY TYPE (2023-2028) 53
8.2.3 ASIA-PACIFIC NEUROSCIENCE MARKET SHARE BY TYPE (2017-2028) 54
8.3 ASIA-PACIFIC NEUROSCIENCE MARKET SIZE BY APPLICATION 54
8.3.1 ASIA-PACIFIC NEUROSCIENCE MARKET SIZE BY APPLICATION (2017-2022) 54
8.3.2 ASIA-PACIFIC NEUROSCIENCE MARKET SIZE BY APPLICATION (2023-2028) 55
8.3.3 ASIA-PACIFIC NEUROSCIENCE MARKET SHARE BY APPLICATION (2017-2028) 55
8.4 ASIA-PACIFIC NEUROSCIENCE MARKET SIZE BY REGION 56
8.4.1 ASIA-PACIFIC NEUROSCIENCE MARKET SIZE BY REGION (2017-2022) 56
8.4.2 ASIA-PACIFIC NEUROSCIENCE MARKET SIZE BY REGION (2023-2028) 56
8.4.3 CHINA 58
8.4.4 JAPAN 59
8.4.5 SOUTH KOREA 60
8.4.6 SOUTHEAST ASIA 61
8.4.7 INDIA 62
8.4.8 AUSTRALIA 63
9 LATIN AMERICA 64
9.1 LATIN AMERICA NEUROSCIENCE MARKET SIZE (2017-2028) 64
9.2 LATIN AMERICA NEUROSCIENCE MARKET SIZE BY TYPE 64
9.2.1 LATIN AMERICA NEUROSCIENCE MARKET SIZE BY TYPE (2017-2022) 64
9.2.2 LATIN AMERICA NEUROSCIENCE MARKET SIZE BY TYPE (2023-2028) 65
9.2.3 LATIN AMERICA NEUROSCIENCE MARKET SHARE BY TYPE (2017-2028) 66
9.3 LATIN AMERICA NEUROSCIENCE MARKET SIZE BY APPLICATION 66
9.3.1 LATIN AMERICA NEUROSCIENCE MARKET SIZE BY APPLICATION (2017-2022) 66
9.3.2 LATIN AMERICA NEUROSCIENCE MARKET SIZE BY APPLICATION (2023-2028) 67
9.3.3 LATIN AMERICA NEUROSCIENCE MARKET SHARE BY APPLICATION (2017-2028) 67
9.4 LATIN AMERICA NEUROSCIENCE MARKET SIZE BY COUNTRY 68
9.4.1 LATIN AMERICA NEUROSCIENCE MARKET SIZE BY COUNTRY (2017-2022) 68
9.4.2 LATIN AMERICA NEUROSCIENCE MARKET SIZE BY COUNTRY (2023-2028) 68
9.4.3 MEXICO 70
9.4.4 BRAZIL 71
10 MIDDLE EAST & AFRICA 72
10.1 MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE (2017-2028) 72
10.2 MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE BY TYPE 72
10.2.1 MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE BY TYPE (2017-2022) 72
10.2.2 MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE BY TYPE (2023-2028) 73
10.2.3 MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SHARE BY TYPE (2017-2028) 74
10.3 MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE BY APPLICATION 74
10.3.1 MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE BY APPLICATION (2017-2022) 74
10.3.2 MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE BY APPLICATION (2023-2028) 75
10.3.3 MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SHARE BY APPLICATION (2017-2028) 75
10.4 MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE BY COUNTRY 76
10.4.1 MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE BY COUNTRY (2017-2022) 76
10.4.2 MIDDLE EAST & AFRICA NEUROSCIENCE MARKET SIZE BY COUNTRY (2023-2028) 76
10.4.3 TURKEY 78
10.4.4 GCC COUNTRIES 79
10.4.5 ISRAEL 80
11 KEY PLAYERS PROFILES 81
11.1 SIEMENS HEALTHINEERS 81
11.1.1 SIEMENS HEALTHINEERS COMPANY DETAILS 81
11.1.2 SIEMENS HEALTHINEERS BUSINESS OVERVIEW 81
11.1.3 SIEMENS HEALTHINEERS NEUROSCIENCE INTRODUCTION 82
11.1.4 SIEMENS HEALTHINEERS REVENUE IN NEUROSCIENCE BUSINESS (2017-2022) 85
11.2 GE HEALTHCARE 85
11.2.1 GE HEALTHCARE COMPANY DETAILS 85
11.2.2 GE HEALTHCARE BUSINESS OVERVIEW 86
11.2.3 GE HEALTHCARE NEUROSCIENCE INTRODUCTION 86
11.2.4 GE HEALTHCARE REVENUE IN NEUROSCIENCE BUSINESS (2017-2022) 87
11.3 PHILIPS 88
11.3.1 PHILIPS COMPANY DETAILS 88
11.3.2 PHILIPS BUSINESS OVERVIEW 89
11.3.3 PHILIPS NEUROSCIENCE INTRODUCTION 89
11.3.4 PHILIPS REVENUE IN NEUROSCIENCE BUSINESS (2017-2022) 90
11.4 CANON 90
11.4.1 CANON COMPANY DETAILS 90
11.4.2 CANON BUSINESS OVERVIEW 91
11.4.3 CANON NEUROSCIENCE INTRODUCTION 91
11.4.4 CANON REVENUE IN NEUROSCIENCE BUSINESS (2017-2022) 92
11.5 HITACHI 93
11.5.1 HITACHI COMPANY DETAILS 93
11.5.2 HITACHI BUSINESS OVERVIEW 94
11.5.3 HITACHI NEUROSCIENCE INTRODUCTION 94
11.5.4 HITACHI REVENUE IN NEUROSCIENCE BUSINESS (2017-2022) 95
11.6 MEDTRONIC 96
11.6.1 MEDTRONIC COMPANY DETAILS 96
11.6.2 MEDTRONIC BUSINESS OVERVIEW 96
11.6.3 MEDTRONIC NEUROSCIENCE INTRODUCTION 97
11.6.4 MEDTRONIC REVENUE IN NEUROSCIENCE BUSINESS (2017-2022) 98
11.7 LEICA MICROSYSTEMS 98
11.7.1 LEICA MICROSYSTEMS COMPANY DETAILS 98
11.7.2 LEICA MICROSYSTEMS BUSINESS OVERVIEW 99
11.7.3 LEICA MICROSYSTEMS NEUROSCIENCE INTRODUCTION 100
11.7.4 LEICA MICROSYSTEMS REVENUE IN NEUROSCIENCE BUSINESS (2017-2022) 100
11.8 ZEISS 101
11.8.1 ZEISS COMPANY DETAILS 101
11.8.2 ZEISS BUSINESS OVERVIEW 102
11.8.3 ZEISS NEUROSCIENCE INTRODUCTION 103
11.8.4 ZEISS REVENUE IN NEUROSCIENCE BUSINESS (2017-2022) 106
11.9 NIKON 107
11.9.1 NIKON COMPANY DETAILS 107
11.9.2 NIKON BUSINESS OVERVIEW 107
11.9.3 NIKON NEUROSCIENCE INTRODUCTION 108
11.9.4 NIKON REVENUE IN NEUROSCIENCE BUSINESS (2017-2022) 109
11.10 JEOL LTD 110
11.10.1 JEOL LTD COMPANY DETAILS 110
11.10.2 JEOL LTD BUSINESS OVERVIEW 110
11.10.3 JEOL LTD NEUROSCIENCE INTRODUCTION 111
11.10.4 JEOL LTD REVENUE IN NEUROSCIENCE BUSINESS (2017-2022) 112
11.11 NATUS MEDICAL 113
11.11.1 NATUS MEDICAL COMPANY DETAILS 113
11.11.2 NATUS MEDICAL BUSINESS OVERVIEW 113
11.11.3 NATUS MEDICAL NEUROSCIENCE INTRODUCTION 114
11.11.4 NATUS MEDICAL REVENUE IN NEUROSCIENCE BUSINESS (2017-2022) 114
11.12 NIHON KOHDEN 115
11.12.1 NIHON KOHDEN COMPANY DETAILS 115
11.12.2 NIHON KOHDEN BUSINESS OVERVIEW 116
11.12.3 NIHON KOHDEN NEUROSCIENCE INTRODUCTION 116
11.12.4 NIHON KOHDEN REVENUE IN NEUROSCIENCE BUSINESS (2017-2022) 117
11.13 NEUROPACE INC 118
11.13.1 NEUROPACE INC COMPANY DETAILS 118
11.13.2 NEUROPACE INC BUSINESS OVERVIEW 119
11.13.3 NEUROPACE INC NEUROSCIENCE INTRODUCTION 119
11.13.4 NEUROPACE INC REVENUE IN NEUROSCIENCE BUSINESS (2017-2022) 119
11.14 SHIMADZU CORPORATION 120
11.14.1 SHIMADZU CORPORATION COMPANY DETAILS 120
11.14.2 SHIMADZU CORPORATION BUSINESS OVERVIEW 121
11.14.3 SHIMADZU CORPORATION NEUROSCIENCE INTRODUCTION 121
11.14.4 SHIMADZU CORPORATION REVENUE IN NEUROSCIENCE BUSINESS (2017-2022) 122
11.15 COMPUMEDICS 123
11.15.1 COMPUMEDICS COMPANY DETAILS 123
11.15.2 COMPUMEDICS BUSINESS OVERVIEW 124
11.15.3 COMPUMEDICS NEUROSCIENCE INTRODUCTION 124
11.15.4 COMPUMEDICS REVENUE IN NEUROSCIENCE BUSINESS (2017-2022) 126
11.16 NOLDUS INFORMATION TECHNOLOGY 127
11.16.1 NOLDUS INFORMATION TECHNOLOGY COMPANY DETAILS 127
11.16.2 NOLDUS INFORMATION TECHNOLOGY BUSINESS OVERVIEW 128
11.16.3 NOLDUS INFORMATION TECHNOLOGY NEUROSCIENCE INTRODUCTION 128
11.16.4 NOLDUS INFORMATION TECHNOLOGY REVENUE IN NEUROSCIENCE BUSINESS (2017-2022) 129
11.17 PLEXON 130
11.17.1 PLEXON COMPANY DETAILS 130
11.17.2 PLEXON BUSINESS OVERVIEW 130
11.17.3 PLEXON NEUROSCIENCE INTRODUCTION 131
11.17.4 PLEXON REVENUE IN NEUROSCIENCE BUSINESS (2017-2022) 132
11.18 NEURONEXUS 132
11.18.1 NEURONEXUS COMPANY DETAILS 132
11.18.2 NEURONEXUS BUSINESS OVERVIEW 133
11.18.3 NEURONEXUS NEUROSCIENCE INTRODUCTION 133
11.18.4 NEURONEXUS REVENUE IN NEUROSCIENCE BUSINESS (2017-2022) 135
11.19 PHOENIX TECHNOLOGY GROUP 136
11.19.1 PHOENIX TECHNOLOGY GROUP COMPANY DETAILS 136
11.19.2 PHOENIX TECHNOLOGY GROUP BUSINESS OVERVIEW 137
11.19.3 PHOENIX TECHNOLOGY GROUP NEUROSCIENCE INTRODUCTION 137
11.19.4 PHOENIX TECHNOLOGY GROUP REVENUE IN NEUROSCIENCE BUSINESS (2017-2022) 138
12 ANALYST'S VIEWPOINTS/CONCLUSIONS 139
13 APPENDIX 140
13.1 RESEARCH METHODOLOGY 140
13.1.1 METHODOLOGY/RESEARCH APPROACH 140
13.1.2 DATA SOURCE 143
13.2 DISCLAIMER 146
13.3 AUTHOR DETAILS 146